Whitmore Bradford T 的 Form 4 申報
Clearside Biomedical, Inc.（CLSD），2021/9/1 申報
- 申報編號
- 0000933430-21-000005
- 申報時間
- 2021/9/1
- 交易日
- 2021/8/30-9/1
- 申報延遲
- 2 天
- 10b5-1 計畫
- 表單沒有這欄（2023 年以前）
這份申報列了 3 筆非衍生性交易。公開市場賣出合計 $292.0 萬。交易後 2 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Whitmore Bradford TCIK 0000933430 | 持股 10% 以上大股東 |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F1
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.97 to $7.42. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on this Form 4.
表 I 有 1 筆交易的價格引用這則附註。
- F3
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.8499 to $7.21. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on this Form 4.
表 I 有 1 筆交易的價格引用這則附註。
- F4
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.66 to $7.09. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on this Form 4.
表 I 有 1 筆交易的價格引用這則附註。